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Liver natural killer (NK) cells were recently reported to possess memory-like properties in contact hypersensi-
tivity (CHS) models. However, the phenotype and origin of these “memory” NK cells cannot be distinguished 
from other NK cell subpopulations. Here, we define the transcriptional, phenotypic, and functional features 
of liver NK cell subsets and their roles in mediating CHS. Liver NK cells can be divided into two distinct sub-
sets: CD49a+DX5– and CD49a–DX5+. Substantial transcriptional and phenotypic differences existed between 
liver CD49a+DX5– NK cells and other NK cell subsets. CD49a+DX5– NK cells possessed memory potential and 
conferred hapten-specific CHS responses upon hapten challenge. Importantly, CD49a+DX5– NK cells were 
liver resident and were present in the liver sinusoidal blood, but not the afferent and efferent blood of the liver. 
Moreover, they appeared to originate from hepatic hematopoietic progenitor/stem cells (HPCs/HSCs) but not 
from the bone marrow, and maintained their phenotypes in the steady state. Our findings of liver-resident NK 
cells shed new light on the acquisition of memory-like properties of NK cells.
Introduction
Natural killer (NK) cells are important components of the innate 
immune system (1–3). Unlike T and B cells, NK cells efficiently exert 
their effector functions, classically without the necessity of prior 
sensitization, and mainly through direct cytotoxicity and the pro-
duction of various cytokines, thus providing the first line of defense 
against pathogens and tumors. NK cells are thought to develop 
primarily in the bone marrow (BM) during adult life (4, 5), and NK 
cell maturation is a multistep process associated with progressive 
acquisition and/or downregulation of a series of markers (6). NK cell 
precursors (NKPs), expressing CD122 and lacking NK cell–specific 
markers, are traditionally defined as comprising the first stage of NK 
lineage commitment and can give rise to immature NK cells after 
acquisition of NK 1.1 in C57BL/6 (B6) mice (7). Immature NK cells 
further differentiate into mature NK cells, involving the sequential 
expression of DX5 (CD49b), CD11b, KLRG1, and CD27 (6, 8–10). 
Although mature NK cells represent the main NK cell population in 
the peripheral organs, there is accumulating evidence that phenotyp-
ically immature NK cells are not unique to the BM, suggesting that 
NK cell development may also take place at peripheral sites (11–13) 
or that these cells may represent distinct NK cell subsets.
As innate immune effectors, NK cells have long been considered to 
lack immunological memory, a hallmark of adaptive immune cells. 
NK cells do not express recombination-activating gene (RAG) pro-
teins, which are necessary for recombination events that are required 
to generate a large repertoire of diverse antigen-specific receptors in 
T and B cells (14, 15). Strikingly, however, recent findings demon-
strated that NK cells can mount a robust recall response following 
specific activation by chemical haptens (16–18) or viruses (17, 19, 
20), or nonspecific activation by cytokines (21), respectively. Among 
the NK cells examined for apparent “antigen-specific” responses, 
hepatic but not splenic NK cells confer hapten- or virus-specific 
responses, whereas conventional splenic NK cells can mediate 
memory-like effects following murine cytomegalovirus (MCMV) 
and cytokine stimulation (19, 21). Particularly, in contact hypersen-
sitivity (CHS) and non-MCMV studies, hapten- and virus-specific 
“memory” liver NK cells express Ly49C/I (16), CXCR6 (17), and/or 
Thy1 (20). However, these molecules are expressed on other cells, 
including splenic NK cells (1, 15). Therefore, liver NK cells endowed 
with memory-like properties do not have a phenotype that can dis-
tinguish them from other NK cells.
On the other hand, previous studies have suggested that liver 
NK cells may be phenotypically distinct from conventional splenic 
NK cells, which in turn resemble NK cells in peripheral blood. For 
example, the liver contains an unusually high proportion (up to 
50%) of phenotypically immature NK cells, expressing TNF- related 
apoptosis-inducing ligand (TRAIL) and lacking DX5 (6, 11, 22), 
whereas NK cells at other peripheral sites are predominantly 
mature in phenotype and function. Notably, during early life, the 
phenotypically immature NK cells are predominant in the liver 
and can also be found in the spleen (11). In contrast to the sharp 
decline of these NK cells in the spleen after birth, in the liver they 
only mildly decrease with age and maintain a stable subpopulation 
in adult mice (11). Finally, these liver NK cells have relatively low 
proliferative capacity in the steady state (22). Thus, these studies 
suggest that there may be an organ-specific, i.e., liver-specific, NK 
cell population endowed with memory-like properties and distin-
guishable from conventional NK cells in the spleen and peripheral 
circulation, perhaps akin to thymic NK cells (13).
Challenges to identifying such a putative liver-specific NK cell 
subpopulation relate to several unique aspects of the liver, includ-
ing two afferent vascular supplies and distinctive immunolog-
ical features. Through the portal vein that drains the abdomi-
nal organs including the spleen, the liver receives about 75% of 
its afferent blood, exposing the liver to a variety of antigens and 
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microbial products from the gastrointestinal tract. This nutri-
ent-rich blood mixes with oxygenated blood from the hepatic 
artery in the sinusoids, a highly fenestrated, low-pressure vascular 
system containing many innate immune cells, especially NK cells. 
Interestingly, NK cells are difficult to identify on liver tissue sec-
tions, consistent with their residence in the sinusoids rather than 
in the liver parenchyma per se (23). Thus, if the liver contains a 
liver-resident NK cell population, the cells should reside in the 
sinusoids where they are mixed with circulating NK cells, which 
may be phenotypically distinguishable.
Herein, we precisely describe the fundamental features of liv-
er-resident NK cells. We characterized their unique phenotype as 
CD49a+DX5–, and found that they are involved in the immunolog-
ical memory response in NK cell–mediated CHS models and that 
their hematopoietic progenitor cells (HPCs) and precursors exist 
in the liver. Thus, our experiments suggest that liver-resident NK 
cells confer memory-like responses in CHS.
Results
Hepatic DX5– NK cells confer CHS responses. Since hepatic NK cells, but 
not splenic NK cells, can elicit hapten-specific CHS responses (16, 17), 
we hypothesized that the phenomenon was due to a distinct NK cell 
subset present in the liver and not in the spleen. One clue to this sub-
set was the description of DX5– NK cells enriched in the liver that were 
speculated to be an immature population similar to one identified in 
the BM (6). Here, we examined the expression of DX5 and NK1.1 on 
CD122+CD3–CD19– cells from different organs in B6 mice (Figure 1, 
A and B). Consistent with previous findings, DX5–NK1.1– cells resem-
bling NKPs were detectable in the BM, liver, spleen, and lymph nodes 
(12). The DX5+NK1.1+ subset, defined as conventional NK cells, was 
abundant in all examined organs. Surprisingly, however, nearly half of 
hepatic NK1.1+ NK cells were DX5–, whereas approximately 5%–8% of 
NK1.1+ NK cells in other organs were DX5–.
To test the potential role of the DX5– subset in CHS, we sensi-
tized Rag1–/– or WT mice with oxazolone (OXA) then adoptively 
transferred their DX5– or DX5+ liver NK cells into naive WT recip-
ients. One month later, recipients were challenged with OXA and 
ear swelling was measured. Only recipients that received sensi-
tized hepatic DX5– NK cells displayed marked ear inflammation, 
whereas recipients of sensitized hepatic DX5+ NK cells or sensi-
tized splenic NK cells were unresponsive (Figure 1, C and D). Thus, 
the immunological memory capacity of liver NK cells in CHS 
models can be attributed to hepatic DX5– NK cells, suggesting that 
hepatic DX5– NK cells are functionally distinct from hepatic DX5+ 
and splenic NK cells, potentially as a unique subset.
“Memory” NK cells remain DX5– during hapten priming in the liver. To 
verify whether the sensitized “memory” NK cells are naive hepatic 
DX5– NK cells, but not differentiated from other NK cell subsets 
including both non-liver NK cells and DX5+ NK cells, we trans-
ferred naive hepatic DX5– or DX5+ NK cells sorted from GFP trans-
genic mice into lethally irradiated recipients followed by sensitiza-
tion with OXA at days 1 and 2. The liver mononuclear cells (MNCs) 
from the lethally irradiated recipients were isolated at day 5 (before 
irradiation-induced death), and adoptively transferred by intrave-
nous injection into secondary naive recipients, which was followed 
by challenge 1 month later (Figure 2A). Before secondary transfer, 
Figure 1
Hepatic DX5– NK cells confer memory responses in CHS. (A) Expression of DX5 versus NK1.1 was analyzed on CD122+CD3–CD19– cells from 
liver, spleen, peripheral blood, BM, and iLNs of WT B6 mice. Representative FACS plots are shown. (B) The percentages of DX5– NK cells among 
NK (CD122+NK1.1+CD3–CD19–) cells in different organs are shown (n = 7). (C) Ear swelling in naive B6 mice that received 8 × 104 DX5+ (n = 6) 
or DX5– (n = 4) NK (NK1.1+ CD3– CD19–) cells from OXA-sensitized Rag1−/− donor liver. Recipients were challenged 1 month later with OXA on 
1 ear and solvent on the other. (D) Ear swelling in naive B6 mice that received 8 × 104 hepatic NK cell subsets (n = 3 per group) or splenic NK 
cells (n = 6) from OXA-sensitized WT mice and were challenged 1 month later. (C and D) Data are from 1 experiment representative of at least 2 
independent experiments. **P < 0.01; ***P < 0.001. Unpaired Student’s t test (C) or ANOVA (D). Means ± SEM are shown in B–D.
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donor GFP+DX5– NK cells in irradiated recipients remained DX5– 
following sensitization with OXA, and donor GFP+DX5+ NK cells 
consistently maintained expression of DX5 (Figure 2B), indicating 
that hapten sensitization did not affect DX5 expression on NK 
cells. Importantly, we found that only secondary recipients that 
received liver MNCs from the first sensitized recipients, which in 
turn had received naive hepatic DX5– NK cells, could mount hap-
ten-specific CHS responses (Figure 2C). These results demonstrate 
that only naive hepatic DX5– NK cells, not other NK cell subsets, 
have memory potential.
Taken together with the rarity of naive DX5– NK cells in periph-
eral tissues except the liver, these findings raise the possibility 
that the liver may be a site where naive NK cells are primed, in 
which case haptens would need to be delivered to the liver to elicit 
Figure 2
Hepatic NK cells with memory capacity remain DX5– during hapten sensitization. (A) DX5– or DX5+ NK (NK1.1+CD3–CD19–) cells (105) from naive 
GFP transgenic mice were adoptively transferred into lethally irradiated recipients, which were sensitized with 5% OXA on days 1 and 2. On day 
5, liver MNCs from recipients or control irradiated mice that did not receive any cells were adoptively transferred into secondary recipients that 
were challenged 1 month later. (B) DX5 expression on GFP+ NK cells in the irradiated recipients that received GFP+DX5– (top panel) or GFP+DX5+ 
(bottom panel) NK cells was analyzed on day 5 before transfer. (C) Ear swelling of secondary recipients described in A was measured after OXA 
challenge (n = 5 per group). ***P < 0.001, ANOVA. Means ± SEM are shown. Hepatocytes (D) or F4/80+ Kupffer cells (E) in the liver of sensitized 
(blue) or control (gray shaded) WT mice were respectively isolated by a 2-step collagenase perfusion method, then gated and analyzed for FITC 
expression; the statistical results show FITC MFI on sensitized (n = 6) or control (n = 2) hepatocytes. *P < 0.05, unpaired Student’s t test. Means 
± SEM are shown. (F) FITC+ cells in Rag1–/– mice 24 hours after sensitization of FITC on 2 consecutive days. Rag1–/– mice without sensitization 
were set as controls. FITC+ cells among liver MNCs from sensitized mice were analyzed for the expression of indicated markers. (B–F) Data are 
representative of 2 or 3 independent experiments. SSC, side scatter.
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CHS responses. To examine this hypothesis, we sensitized naive 
WT mice with the hapten FITC and found that FITC fluores-
cence on hepatocytes of sensitized mice was detected as opposed 
to normal autofluorescence of hepatocytes (Figure 2D), implying 
that hepatocytes may absorb haptens after sensitization and con-
sistent with the liver as a possible site for hapten sensitization. 
However, Kupffer cells, the resident macrophages in the liver, 
seemed less likely to be involved in this process, as FITC+ expres-
sion was only very rarely detectable in the Kupffer cell population 
(Figure 2E). Accordingly, FITC-laden cells infiltrated the liver, 
but there were no FITC+ cells in the spleen in FITC-sensitized 
Rag1–/– mice (Figure 2F). Phenotypic assessment of these liver 
FITC+ cells revealed that they were NK1.1loLy6Glo cells, with some 
cells expressing CD11c and CD11b. Further analysis showed that 
double-positive CD11b+CD11c+ cells existed among FITC+ cells, 
suggestive of the involvement of dendritic cells in NK cell prim-
ing. Also, CD11b+F4/80+Gr-1+ cells with monocyte phenotypes 
were observed, indicating that circulating macrophages may also 
function as APCs. Thus, the retention of circulating cells with anti-
gen-presenting ability in the liver makes it possible that DX5– NK 
cells are directly primed in the liver.
Preferential trafficking of DX5– NK cells to the liver without further dif-
ferentiation. In our initial studies to investigate whether DX5– NK 
cells selectively reside in the liver, we adoptively transferred unsep-
arated liver MNCs from CD45.1+ mice into sublethally irradiated 
CD45.2+ recipients via intravenous injection. One day after trans-
fer, we found that donor-derived DX5– NK cells accumulated only 
in the liver, whereas donor-derived DX5+ NK cells showed distri-
bution to other sites (Figure 3A), suggestive of distinct migratory 
tendencies between these 2 subsets. However, it is possible that this 
result is due to rapid conversion from DX5– to DX5+ NK cells in 
various tissues except the liver, and that there is no intrinsic dif-
ference between them in migratory capacity. To further determine 
whether they differ in tissue migration, we adoptively transferred 
sorted DX5– and DX5+ liver NK cells and analyzed recipient mice; 
we consistently found that donor-derived DX5– NK cells were only 
detected in the host liver, whereas donor-derived DX5+ NK cells 
were found in both the host liver and spleen (Figure 3B). To fur-
ther confirm the preferential migration of DX5– NK cells to the 
liver, we used another marker of donor NK cells on the purified 
DX5– or DX5+ liver NK cells, i.e., the stable expression of GFP, and 
a different route of transfer. Following adoptive transfer into sub-
lethally irradiated recipients via intraperitoneal injection, donor 
GFP+DX5– NK cells were only found in the liver (Supplemental 
Figure 1; supplemental material available online with this arti-
cle; doi:10.1172/JCI66381DS1). Moreover, transferred DX5– NK 
cells remained DX5– in recipient liver (Figure 3B), suggesting that 
hepatic DX5– NK cells are phenotypically stable and do not dif-
ferentiate into DX5+ NK cells in the steady state. Thus, compared 
with nondiscriminatory migration of the DX5+ subset to different 
tissues, hepatic DX5– NK cells preferentially traffic to the liver and 
have a low capacity to repopulate other tissues after transfer.
The transcriptional, phenotypic, and functional features of hepatic DX5– 
NK cells. We next sought to determine other differences between 
DX5– and DX5+ NK cells in transcriptional signature, phenotype, 
and functional capacity. DX5–NK1.1+ and DX5+NK1.1+ liver NK 
cells were respectively sorted for gene expression microarray anal-
ysis (GEO accession number GSE43339). With nearly 22,000 genes 
tested, 11,122 expressed genes showed no change in DX5– versus 
DX5+ NK cells, while 1,507 expressed genes showed a fold change of 
2 or greater, among which 566 genes were overexpressed in DX5– NK 
cells (Figure 4A). The differentially expressed genes included those 
encoding inhibitory and activating receptors, cytokines, chemok-
ines, adhesion molecules, cytokine receptors, cytotoxic effectors, 
and transcription factors (Figure 4B). We confirmed several of these 
findings by flow cytometry (Supplemental Table 1). Molecules asso-
Figure 3
Hepatic DX5– NK cells preferentially traffic to the liver and maintain their phenotypic features after adoptive transfer. (A) Liver MNCs (106) from 
CD45.1+ mice were adoptively transferred intravenously into sublethally irradiated (IR) CD45.2+ B6 mice. Twenty-four hours after transfer, CD45.1+ 
NK (NK1.1+CD3–CD19–) cells were analyzed for DX5 expression in recipient liver, spleen, and BM. (B) DX5– or DX5+ liver NK cells (105) were 
sorted from CD45.1+ mice and intravenously transferred into sublethally irradiated CD45.2+ B6 mice. DX5 expression of donor NK cells before 
transfer is shown pre- and post-sort. Seven days after transfer, CD45.1+ NK cells were analyzed for DX5 expression in recipient liver and spleen. 
All data in this figure are representative of 2 independent experiments.
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Figure 4
Hepatic DX5– NK cells are distinct from other NK cell populations. (A) Comparative 
transcriptome analysis between DX5– and DX5+ liver NK (NK1.1+CD3–) cells was 
performed by Affymetrix GeneChip Mouse Genome 430 2.0 arrays. Genes that were 
expressed greater than or equal to 2-fold higher or lower than DX5+ NK cells are 
highlighted in black. The number of genes upregulated or downregulated for each 
comparison is indicated. (B) Differentially expressed genes in DX5– and DX5+ NK 
cells were selected and classified into different groups. The listed genes had greater 
than or equal to 2-fold differences and are shown with their signal values. (C) Dis-
tribution by functional category of upregulated genes in hepatic DX5+ and DX5– NK 
cell subsets. Genes with greater than or equal to 2-fold differences were included. 
(D) Expression of CD107a and IFN-γ is shown for stimulated DX5– and DX5+ liver 
NK (NK1.1+CD3–CD19–) cells. Liver MNCs were stimulated with IL-2 and IL-12 (for 
IFN-γ analysis) or with YAC-1 cells (for CD107a analysis). Blue lines represent stain-
ing of the indicated molecules, and gray-shaded curves represent isotype controls. 
(E) Statistical results of percentages of CD107a+ (n = 6) or IFN-γ+ (n = 11) cells are 
shown. *P < 0.05 and **P < 0.01, paired Student’s t test. Means ± SEM are shown.
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ciated with adhesion, such as CD49a and CD51, and chemokine 
receptors, CXCR3 and CXCR6, were upregulated on DX5– NK cells 
at both transcript and protein levels. We consistently found that 
CD69 was expressed at higher levels on DX5– NK cells, but not on 
S1PR1, which is regulated by CD69 (24). Some adhesion molecules, 
such as CD62L (Sell), CD11b (Itgam), CD29 (Itgb1), and CCR9 (Ccr9), 
were significantly downregulated on DX5– NK cells. In addition, we 
observed that Il21r, Rora, and Ahr, which are related to IL-17 produc-
tion and Th-17 cell development (25), were also relatively higher in 
DX5– NK cells. Eomes, which is implicated in inducing IFN-γ produc-
tion (26) and NK cell maturation (22), was expressed at much higher 
levels in DX5+ NK cells. These differentially expressed transcription 
factors may reflect the distinct patterns of cytokines released by 
those 2 NK cell subsets. Genes encoding LAG-3, Helios, and Egr-2, 
which are preferentially expressed by Treg cells (27–29), were also 
found to be overexpressed by DX5– NK cells, raising the possibility 
that DX5– NK cells may exert negative regulatory actions within the 
liver. Interestingly, Cd3g, which has been previously reported to be 
expressed in fetal NK cells (30) was highly expressed in DX5– NK 
cells, supporting the possibility of common origins between NK and 
T cells. In brief, we found that genes associated with immune toler-
ance, negative regulation, and activation were enhanced in DX5– NK 
cells, while DX5+ NK cells were relatively enriched in genes associ-
ated with migration, immune response, proliferation, and cell mat-
uration (Figure 4C and Supplemental Table 2).
Regarding function, effector molecules such as TRAIL (Tnfsf10), 
granzyme c (Gzmc), and granzyme f (Gzmf) were overexpressed in 
DX5– NK cells, implying that DX5– NK cells are functional. How-
ever, stimulation assays showed that DX5– NK cells expressed 
markedly lower levels of CD107a, a degranulation marker of cyto-
toxic NK cells, and produced slightly lower levels of IFN-γ than 
DX5+ NK cells after activation (Figure 4, D and E). These data sug-
gest that the 2 NK cell subsets are functionally different. Further 
analysis revealed that DX5+ NK cells of the liver phenotypically 
resembled those of the spleen (Supplemental Figure 2). Hence, 
previous findings that bulk liver NK cells are phenotypically dif-
ferent from NK cells in other organs (6, 11, 31) may be due to the 
unique DX5– subset of NK cells in the liver.
As the primary site for NK cell development (4, 5), the BM also 
contains a very small subpopulation of DX5– NK cells which were 
considered to be immature NK cells (6, 7). Indeed, the low expres-
sion of Ly49 receptors and the high expression of NKG2A on liver 
DX5– NK cells are consistent with a phenotypically immature 
population (6, 31). However, TRAIL was not expressed on BM 
DX5– NK cells, in contrast to highly expressed TRAIL on hepatic 
DX5– NK cells (ref. 11 and Supplemental Figure 3). Meanwhile, 
hepatic DX5– NK cells expressed much higher CD11c than did 
BM DX5– NK cells, indicating that hepatic DX5– NK cells are phe-
notypically different from those of the BM that are considered 
to be immature NK cells (7). Taken together, the results indicate 
that hepatic DX5– NK cells are distinct from DX5+ NK cells and 
DX5– NK cells at other sites in transcriptional, phenotypic, and 
functional aspects.
CD49a+DX5– NK cells are liver resident. DX5 is widely used to define 
NK cells in mouse strains that are NK1.1– (12), and identification 
of DX5– would not be useful as a marker of hepatic NK cell subsets 
in such strains, indicating that a “positive marker” to define liver 
NK cell subsets is necessary. By transcriptome analysis, we found 
that Cd49a, also known as Itga1, was the most highly expressed 
gene (20-fold higher) among the top 20 most upregulated genes 
in DX5– NK cells (Supplemental Figure 4). Selective expression was 
further verified by flow cytometry, showing that CD49a was con-
stitutively and highly expressed by hepatic DX5– NK cells, but not 
by hepatic DX5+ NK cells or NK cells from other tissues (Figure 
5A). In addition, NKp46, a pan-NK cell marker (32), was expressed 
at high levels on both DX5– and DX5+ NK cells. Though CD51 
was expressed by the majority of DX5– NK cells, a proportion of 
DX5+ NK cells were also CD51+ regardless of tissue origin. The 
expression of CD27 and Thy1.2 on NK cells has been reported to 
be associated with immune memory by hepatic NK cells (16, 20, 
33), but their expression was detected on NK cells from each exam-
ined tissue. CXCR6 was found to be required for NK cell–mediated 
CHS responses (17), but NK cells from other organs besides liver 
also expressed CXCR6, and a fraction of hepatic DX5– NK cells 
did not express CXCR6 (Figure 5A), suggesting that it is not an 
exclusive marker of liver NK cells. After adoptive transfer, hepatic 
DX5– NK cells maintained stable expression of CD49a in recipi-
ents, while hepatic DX5+ NK cells were still CD49a– (Figure 5B). 
Furthermore, hepatic CD49a+ NK cells were identified in BAL-
B/c and Rag1–/– mice as well as in B6 mice (Figure 5C), and they 
were selectively accompanied by high expression of TRAIL, CD51, 
CXCR3, LAG3, CD44, and CD2 (Supplemental Figure 5), similar 
to what was observed in B6 mice (Supplemental Table 1). Thus, 
these results strongly suggest that CD49a+DX5– NK cells represent 
an NK cell subset that preferentially resides in the liver.
Importantly, we observed that the CD49a+DX5– NK cells 
resided neither in afferent (arterial or portal venous) nor in effer-
ent (postcaval venous) blood of the liver as opposed to CD49a–
DX5+ NK cells (Figure 5D). Instead, CD49a+DX5– NK cells were 
present in the liver sinusoidal blood. Immunofluorescence and 
immunohistochemistry further confirmed the localization of 
CD49a+ NK cells in the liver sinusoids, albeit somewhat rare on tis-
sue sections (Figure 5, E and F). Moreover, CD49a+DX5– NK cells 
were seldom present in the spleen, BM, lung, and lymph nodes 
(Figure 5A and data not shown).
Furthermore, we studied unmanipulated CD49a+DX5– and 
CD49a–DX5+ NK cells in unirradiated CD45 congenic mice that 
were surgically joined by parabiosis. At the time when substan-
tial chimerism of splenic leukocytes (Supplemental Figure 6) was 
taking place, the CD49a–DX5+ NK cells from each parabiont were 
found in the spleens and livers of both parabionts (Figure 6, A 
and B). However, CD49a+DX5– NK cells expressing CD45.1+ were 
essentially confined to the CD45.1+ livers which contained few, 
if any, CD49a+DX5– NK cells from the CD45.2+ parabiont, and 
vice versa. Taken together with the samplings of the liver afferent, 
efferent, and sinusoidal vasculature, the preferential migration of 
transferred, purified hepatic DX5– NK cells to the liver (Figure 3B) 
and the phenotypic similarities of the DX5+ NK cells in the liver 
and spleen (Supplemental Figure 2) indicate that CD49a+DX5– 
NK cells stably reside in the liver sinusoidal space, whereas CD49a–
DX5+ NK cells are circulating NK cells passing through the liver 
under noninflammatory homeostatic conditions.
CD49a+ NK cells confer hapten-specific CHS responses. The exclusive 
and constitutive expression of CD49a by hepatic DX5– NK cells 
in the steady state prompted us to examine the function of sensi-
tized CD49a+ NK cells in CHS. The recipients of sensitized hepatic 
CD49a+ NK cells displayed vigorous CHS responses after chal-
lenge, whereas recipients of the CD49a– subset failed to respond 
(Figure 7A). Moreover, the magnitude of ear swelling showed a 
nonstatistically significant positive trend for the number of trans-
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ferred hepatic CD49a+ NK cells (Figure 7B). To confirm that the 
recall responses conferred by hepatic CD49a+ NK cells were hap-
ten specific, we adoptively transferred hepatic CD49a+ NK cells 
from OXA- or FITC-primed mice into WT recipients. Only when 
challenged with the sensitizing hapten were the recipients able to 
mount hapten-specific CHS responses; otherwise, the recipients 
were unresponsive (Figure 7, C and D). These data indicate that the 
hepatic CD49a+ NK cells confer hapten-specific CHS responses.
During the memory phase, however, we found that CD49a–DX5+ 
NK cells dramatically increased in the liver and were predom-
inant at the ears after challenge (data not shown). Surprisingly, 
CD49a+DX5– NK cells were still absent in the blood, and NK cells 
at the site of ear swelling after challenge were predominantly 
CD49a–DX5+ by flow cytometric analysis (Supplemental Figure 7 
and data not shown), which raise the possibility that liver-resident 
CD49a+DX5– NK cells may change their phenotype into CD49a–
DX5+ NK cells upon exiting the liver, or at the site of inflamma-
tion, or they may alternatively cooperate with other cells in the 
effector phase of CHS.
Liver-resident HPCs differentiate into CD49a+DX5– NK cells. Since 
NK cells are commonly considered to be derived from BM 
hematopoietic stem cells (BM HSCs) throughout adult life, syn-
geneic BM transplantation (syn-BMT) was performed to inves-
tigate the developmental pathway of hepatic DX5– NK cells. In 
contrast to the enrichment of DX5– NK cells in the livers (nearly 
50%) of normal mice, very few DX5– NK cells (less than 15%) were 
found in the livers of syn-BM transplanted mice even 3 months 
after BMT (Figure 8A), suggesting that DX5– NK cells are not pre-
dominantly derived from BM. We then transplanted liver MNCs 
into lethally irradiated mice, and surprisingly, liver MNCs as well 
as BM HSCs, supported the survival of irradiated mice (Figure 
8B), suggestive of the existence of HSCs in the liver. To further 
address whether the liver contains precursors for this unique NK 
subset, we adoptively transferred a mixture of BM cells contain-
ing heterozygous CD45.1+CD45.2+ double-positive (DP) BM cells 
and homozygous CD45.1+ single-positive (SP) liver MNCs at a 1:1 
ratio into lethally irradiated homozygous CD45.2+ mice (Figure 
8C). DP and SP cells in recipients were analyzed 1 month after 
BMT. Interestingly, liver MNC–derived SP cells were preferentially 
found in the liver rather than in other organs, but BM-derived DP 
NK cells were found mainly in the non-liver organs (Supplemen-
tal Figure 8). In contrast to the predominance of the DX5+ subset 
among DP NK cells differentiated from BM-HSCs, SP NK cells 
derived from liver MNCs were primarily DX5– (Figure 8D), fur-
ther suggesting that the HPCs in hepatic liver MNCs are critical 
for the generation of hepatic DX5– NK cells. In order to exclude 
the influence of homeostatic proliferation by donor NK cells, we 
also transferred purified hepatic CD45.1+ non-T, non-B, non-NK 
precursors (CD3–CD19–NK1.1– cells) together with supporting 
Nfil3–/– BM cells (e.g., NK cell–deficient BM) to lethally irradiated 
recipients. CD49a+DX5– NK cells were generated in the recipient 
liver 1 month after transfer (Figure 8E), demonstrating that there 
are unique direct precursors of the hepatic DX5– NK cell subset in 
the liver, and that the hepatic microenvironment supports their 
further development. Moreover, the presence of CD49a–DX5+ 
NK cells originating from donor hepatic precursors in the liver 
of recipients indicates that the liver also contains HPCs for con-
ventional NK cell development. Thus, these results suggest that 
the liver harbors NK1.1–CD3–CD19– HPCs, which are capable of 
generating liver-resident CD49a+DX5– NK cells, whereas BM cells 
are deficient in giving rise to this NK subset.
Discussion
In this study, we identified a unique NK cell subset residing essen-
tially only in the liver sinusoids, characterized by the CD49a+DX5– 
phenotype and endowed with memory capacity. Previous find-
ings that “memory” NK cells were restricted to the liver (16, 17) 
have generated much interest but have been somewhat puzzling 
regarding their phenotype. Experiments of cell depletion by var-
ious antibodies (16) and adoptive transfer with different NK cell 
subsets (17, 20, 33) had identified markers potentially associated 
with memory, such as Thy1.2, Ly49C/I, CXCR6, and CD27, but 
they were also expressed by splenic NK cells, which did not confer 
memory. Our finding of the exclusive presence of CD49a+DX5– 
NK cells in the liver with memory capacity adds strong support to 
the concept that only hepatic NK cells, but not splenic NK cells, 
confer CHS responses.
Although we found other molecules that tended to be expressed 
on hepatic DX5– NK cells, such as TRAIL, we provide evidence that 
CD49a could be used as a preferred marker of liver-resident NK 
cells. This is likely to be the case in other mouse strains, such as 
BALB/c mice, because CD49a is not known to be a polymorphic 
molecule, unlike NK1.1. CD49a associates with the integrin β1 
subunit (CD29) to form the CD49a/CD29 (VLA-1) heterodimer, a 
major receptor for type IV collagen. Previous reports indicate that 
constitutive VLA-1 expression is largely restricted to mesenchymal 
cells, including smooth muscle cells, stellate cells, and hepatocytes 
(34–36). In the immune system, resting leukocytes seldom express 
VLA-1 (37), with the exception of the liver-resident NK cells 
described here. More recently published studies, however, found 
that viral infection induced T cells to express VLA-1, which was 
required for retention and survival of antigen-specific memory T 
cells in extralymphatic tissues (38, 39). In addition, CD49a expres-
sion was upregulated in both memory NK cells and memory CD8+ 
T cells in the MCMV infection model (40), suggesting that CD49a 
Figure 5
CD49a is a specific surface marker of liver-resident DX5– NK cells. 
(A) Expression of CD49a, NKp46, CD51, CD27, CXCR6, and Thy1.2 
versus DX5 was analyzed on NK1.1+CD3–CD19– cells or NK1.1+CD3– 
cells from the indicated organs of WT or CXCR6+/– (for CXCR6 detec-
tion) mice. Data are representative of 4 to 6 individual mice. (B) DX5– 
or DX5+ liver NK (NK1.1+ CD3– CD19–) cells (105) were sorted from 
CD45.1+ mice and intravenously transferred into sublethally irradiated 
CD45.2+ B6 mice. Seven days later, NK cells from recipient liver were 
analyzed for the expression of CD45.1 and CD49a. Data are represen-
tative of 2 independent experiments. (C) Expression of CD49a was 
analyzed on NK cells from unmanipulated BALB/c and Rag1–/– mice. 
Numbers indicate the percentages of cells expressing CD49a among 
NKp46+CD3–CD19– (BALB/c) or NK1.1+ (Rag1–/–) cells. Blue lines rep-
resent staining of the indicated molecules, and gray-shaded curves 
represent isotype controls. Data are representative of 4 mice per group. 
(D) As described in Methods, blood was collected from the unfraction-
ated liver and other indicated sites from WT B6 mice, and then MNCs 
were isolated. Expression of CD49a versus DX5 was analyzed on 
NK1.1+CD3–CD19– cells. Plots are representative of at least 5 individual 
mice. (E) Immunofluorescence histology of frozen sections of mouse 
liver stained with anti-NKp46 (green), anti-CD31 (blue), anti-CD49a 
(red), or anti-CD49b (DX5; red). Original magnification, ×250. (F) Histo-
logical analysis of Rag1–/– mouse liver stained with anti-CD49a (brown) 
and NK1.1 (purple). Original magnification, ×320. (E and F) Data are 
representative of at least 2 independent experiments.
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may be a common marker for memory lymphocytes. Future stud-
ies to dissect the role of CD49a in hepatic NK cell function will 
therefore require NK cell–specific deletion of CD49a.
In the BM, DX5– NK cells are usually considered to be immature 
NK cells, since they express intermediate levels of many surface 
markers compared with NKP and DX5+ NK cells (7). Moreover, 
DX5– NK cells transferred to sublethally irradiated NK1.1– mice 
(11) or immunodeficient Il2rg–/–Rag2–/– mice (22) can generate 
DX5+ NK cells. In contrast, our data presented here show that 
hepatic DX5– NK cells remain CD49a+DX5– upon transfer to sub-
lethally irradiated syngeneic mice. These results further indicate 
that DX5 alone cannot be used to discriminate immature BM NK 
cells from liver NK cells, and the liver CD49a+DX5– NK cells are 
stable under steady-state circumstances.
Of note, compared with the CD49a+DX5– subset selectively 
located in the liver, CD49a–DX5+ NK cells are the predominant 
NK cell population in the peripheral organs, and they are phe-
notypically similar regardless of organ isolation, suggesting that 
they populate different organs through the systemic circulation. 
By contrast, we did not find CD49a+DX5– NK cells in the affer-
ent or efferent blood of the liver. Moreover, we found that the 
CD49a+DX5– NK cells reside in the sinusoidal blood of the liver. In 
addition, our data show that, after adoptive transfer, CD49a+DX5– 
NK cells preferentially accumulated in the liver and did not 
migrate to the spleen, whereas there was no tissue specificity for 
DX5+ NK cells. Finally, our parabiosis experiments indicate that 
the unmanipulated CD49a+DX5– NK cells are generally confined 
to the liver and do not freely circulate, unlike the CD49a–DX5+ NK 
cells that are found in the liver due to their propensity to circulate 
freely. These findings indicate that under steady-state conditions, 
CD49a+DX5– NK cells are the resident NK cell population of the 
liver, whereas CD49a–DX5+ NK cells are a migratory subset, raising 
the possibility that other tissues may have organ-specific NK cell 
subsets that may be diluted by migratory CD49a–DX5+ NK cells.
Figure 6
Minimal exchange of liver CD49a+DX5– NK cells in parabiotic mice. WT B6 (CD45.2) mice were parabiosed to congenic B6-CD45.1 mice. At day 
14 postsurgery, the spleen and liver were harvested and flow cytometry was performed. (A) Representative dot plot of the liver and spleen gated 
on live CD3–NK1.1+ cells followed by a CD45.1 gate (left panels) and CD45.2 gate (right panels) for each parabiont as indicated. The percentages 
of CD49a+DX5– and CD49a–DX5+ cells are shown in the dot plots. (B) The percentages of CD49a+DX5– and CD49a–DX5+ cells in the liver and 
spleen from A are depicted in the stacked bar graph which represents 7 parabiotic pairs. The CD49a+DX5– NK cells are indicated by the solid 
shading, and the CD49a–DX5+ NK cells are indicated by the open box, with each column representing the indicated parabiont, according to the 
CD45.1+ or CD45.2+ gate.
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the lymph node (15). Inasmuch as CD49a+DX5– NK cells are liver 
resident, it is possible that NK cell “priming” occurs in the liver. 
Consistent with this hypothesis, it should be noted that there are 
very few NK cells in lymph nodes where we found essentially no 
CD49a+DX5– NK cells and where we found that haptens, such as 
FITC, readily traffic to the liver where they are associated with cells 
having phenotypes typically displaying APC function. While our 
data do not exclude that sensitization may result in the recruit-
ment of CD49a+DX5– NK cells to the draining lymph node, sensi-
tized liver CD49a+DX5– NK cells ultimately play a role in “mem-
ory” NK cell responses.
Interestingly, we found few CD49a+DX5– NK cells at the cuta-
neous site of hapten challenge. This surprising finding is likely 
related to recent studies indicating differences in the histology of 
T cell– versus NK cell–mediated CHS reactions, suggesting that 
their effector mechanisms differ (18). Moreover, this study failed 
to find NK cells at the CHS site, which contrasts with our find-
ing that CD49a–DX5+ NK cells were at the CHS lesion, more in 
line with other studies that described NK cells in the lesions (16). 
Our findings may be due to further differentiation of the liver-res-
ident CD49a+DX5– subset, with a loss of CD49a expression after 
exiting the liver, or to other cells that are involved in the effector 
phase of “memory” NK cell responses. Regardless, while these 
postulated effects require further investigation, identification of 
a unique subset of hepatic NK cells provides a new framework for 
the understanding of NK cell “memory.”
Methods
Mice. B6 and BALB/c mice were purchased from the Shanghai Experimen-
tal Animal Center (Shanghai, China). Rag1–/– (B6) and GFP transgenic (B6) 
mice were obtained from the Model Animal Research Center (Nanjing, 
China), which obtained the mice from The Jackson Laboratory. CD45.1+, 
B6.SJL, and Cxcr6–/– (Cxcr6 alleles replaced with cDNA encoding GFP; 
B6 background) mice (44) were purchased from the Jackson Laboratory. 
Cxcr6+/– mice were generated and bred in house. Nfil3+/– (B6) mice were 
provided by Tak W. Mak (University of Toronto, Toronto, Ontario, Can-
ada). Cxcr6+/–, CD45.1+CD45.2+, and Nfil3–/– mice were bred in house. We 
maintained mice in a specific pathogen-free facility for use according to 
the guidelines for experimental animals at the University of Science and 
Technology of China and Washington University.
Antibody staining and flow cytometry. We purchased FITC–anti-Ly49C/I/
F/H, FITC–anti-CD94, PE–anti-CD29, PE–anti-TRAIL, PerCP CY5.5–anti-
CCR7, and purified anti-CX3CR1 from eBioscience, and PE–anti-CCR6 
from R&D Systems. All other antibodies for flow cytometry were pur-
chased from BD Biosciences. Prior to staining with antibodies, cells were 
The liver has long been known to harbor large numbers of NK 
cells, and previous studies have suggested that liver NK cells are 
somewhat different from conventional NK cells (6, 11, 22, 41). 
However, definitive features that distinguish liver and conven-
tional NK cells were not identified previously. Our studies also 
suggest that CD49a+DX5– NK cells may be related to the mor-
phologically identified “pit” cells, which were first demonstrated 
in rat liver (42) and are now known to be NK cells that reside in 
the liver sinusoids. The blood flow within liver sinusoids (43) is 
low, perhaps allowing the CD49a+DX5– NK cells to be retained in 
the liver by adhesion molecules and thus not take up residence at 
other sites.
Although BM is generally considered as the primary organ for 
NK cell generation and development, our results presented here 
indicate an alternative developmental pathway for liver-resident 
NK cells. The low frequency of donor hepatic DX5– NK cells after 
BMT suggests that BM is deficient in generating liver-resident NK 
cells. The survival of lethally irradiated mice receiving liver MNCs 
and the generation of CD49a+DX5– NK cells from liver-resident 
HPCs strongly support the hypothesis that the liver contains the 
precursors of liver-resident NK cells. Furthermore, liver HPCs are 
much more effective at giving rise to hepatic DX5– NK cells than 
BM cells, implying that liver-resident NK cells originate primarily 
from the liver rather than from the BM. Indeed, during fetal life, 
NK cell development occurs in the liver, and CD49a+DX5– NK cells 
are predominant (data not shown), leading to the possibility that 
the “seeds” for CD49a+DX5– NK cells in the liver emerge very early 
in life and persist with age.
Yet, these liver-resident CD49a+DX5– NK cells confer hapten-spe-
cific “memory,” suggesting that they must somehow become sen-
sitized to haptens placed on the skin, perhaps by haptenated cells 
that migrate to the liver. Our new findings thus raise this possibly 
novel scenario that contrasts with traditional views of T cell prim-
ing and the current hypothesized scheme of NK cell “priming” in 
Figure 7
CD49a+ NK cells have the capacity to confer hapten-specific CHS 
responses. (A) Naive B6 mice received 8 × 104 CD49a+ or CD49a– 
liver NK cells from OXA-sensitized WT mice and were challenged 1 
month later (n = 4 per group). (B) Naive B6 mice received the indicated 
number of CD49a+ liver NK cells from OXA-sensitized WT mice and 
were challenged 1 month later (n = 3 per group). (C and D) Naive B6 
mice received 8 × 104 CD49a+ or CD49a– liver NK cells from OXA–-
sensitized (C), or FITC–-sensitized (D) WT mice and were challenged 
with OXA or FITC 1 month later as indicated (n = 4 for the FITC plus 
OXA group; n = 5 for the other groups). All data are from 1 experiment 
representative of 2 independent experiments. *P < 0.05, **P < 0.01, 
and ***P < 0.001, unpaired Student’s t test (A, C, and D), or ANOVA 
(B). Means ± SEM of ear swelling are shown in all panels.
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erythrocytes. PBMCs were obtained by lysing erythrocytes of the blood. 
Lymphocytes of inguinal lymph nodes (iLNs) were obtained by mechani-
cal disruption. Hepatocytes and Kupffer cells were isolated using a 2-step 
collagenase perfusion method as described previously (46).
Cell sorting and transfer. A FACSAria cell sorter (BD Biosciences) was 
used to purify NK cells or different NK cell subsets. Purity of sorted cell 
populations was more than 95%, as verified by post-sort flow cytom-
etry. For the study of CHS, we used unirradiated or lethally irradiated 
(12 Gy given 1 day before adoptive transfer) WT B6 mice that received 
intravenous injection of hepatic NK cell subsets, splenic NK cells, or liver 
MNCs. To study the trafficking and development of liver NK cells, we 
sublethally irradiated (6.5 Gy given 1 or 2 days before adoptive transfer) 
CD45.2+ B6 mice which then received intravenously or intraperitoneally 
delivered liver MNCs, purified DX5–, or DX5+ liver NK cells from CD45.1+ 
or GFP+ B6 mice. For BMT models, lethally irradiated WT B6 mice were 
intravenously given CD45.1+ BM cells alone, CD45.1+CD45.2+ BM cells 
plus CD45.1+CD45.2– liver MNCs, or Nfil3–/– BM cells plus CD45.1+CD3–
CD19–NK1.1– liver cells, respectively.
incubated with rat immunoglobulin for 30 minutes to block Fc receptors. 
We performed flow cytometry on an LSR II (BD Biosciences), and ana-
lyzed data with FlowJo software (Tree Star). To assess IFN-γ production, 
we treated liver MNCs with recombinant human IL-2 (1,000 U/ml; King-
sley) and murine recombinant IL-12 (10 ng/ml; PeproTech) for 18 hours, 
and added monensin (10 μg/ml; Sigma-Aldrich) during the last 4 hours. 
Cells were then collected and stained for surface markers. After fixation 
and permeabilization, cells were intracellularly stained with PE–anti-IFN-γ. 
For CD107a analysis, liver MNCs were incubated with YAC-1 cells at a ratio 
of 1:1 with monensin (10 μg/ml) and PE–anti-CD107a for 4 hours before 
staining with other antibodies.
Cell preparation. Liver MNCs were isolated essentially as described pre-
viously (45). Briefly, we passed livers through a 200-gauge stainless steel 
mesh. The cells were resuspended in 40% Percoll (GE Healthcare), then 
gently overlaid onto 70% Percoll and centrifuged at 1,260 g for 30 minutes. 
Liver MNCs were collected from the interphase. Splenocytes were isolated 
by forcing the spleen through stainless steel mesh and subsequently lysing 
erythrocytes. We obtained BM cells by flushing femurs and then lysing 
Figure 8
The liver retains HPCs capable of generating CD49a+DX5– NK cells. (A) Lethally irradiated CD45.2+ B6 mice that received 2 × 106 BM cells from 
CD45.1+ B6 mice were analyzed for the expression of DX5 on hepatic CD45.1+ NK (NK1.1+CD3–CD19–) cells. Means ± SEM are shown (n = 3 for 
each time point). (B) Survival of lethally irradiated B6 mice that received 3 × 106 BM cells (BMT), liver MNCs (LT), or splenocytes (ST). Lethally 
irradiated mice without transplantation were set as the control group. Means ± SEM are shown (n = 5 per group). (C and D) Lethally irradiated 
CD45.2+ B6 mice received 106 CD45.1+CD45.2+ (DP) BM cells mixed with 106 CD45.1+CD45.2– (SP) liver MNCs. One month after transfer, DP 
and SP cells in the recipient livers were respectively gated to analyze the expression of DX5 on NK cells. Means ± SEM are shown (n = 3 per 
group). (E) BM cells (2 × 106) from Nfil3–/– mice mixed with 105 hepatic NK1.1–CD3–CD19– cells from CD45.1+ B6 mice were transferred into 
lethally irradiated CD45.2+ B6 mice. One month after transfer, CD45.1+ NK cells in the recipient livers were analyzed for the expression of DX5 
and CD49a. All data are representative of 2 independent experiments.
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temperature and the sections were rinsed 3 times in PBS. We performed 
serum blocking by incubating the sections in goat serum for 30 min-
utes at room temperature. Sections were then incubated in anti-CD49a 
(BD Biosciences), and anti-NK1.1 (BD Biosciences) or Armenian ham-
ster IgG2 (BD Biosciences) and mouse IgG2a (BD Biosciences) in a 1:100 
dilution overnight at 4°C and rinsed 3 times in PBS. For detection of 
CD49a, the sections were incubated in goat anti–Armenian hamster IgG-
HRP (Rockland Immunochemicals) in a 1:1,000 dilution for 30 minutes 
at 37°C and rinsed 3 times in PBS. Sections were then incubated in a 
peroxidase substrate solution using DAB (Vector Laboratories) for stable 
brown staining and rinsed in pure water. For NK1.1 staining, an SP-9002 
kit (ZSGB-BIO) was used. Sections were incubated in biotinylated goat 
anti-mouse IgG for 30 minutes at 37°C and rinsed 3 times in PBS. Then 
sections were incubated in streptavidin-HRP for 30 minutes at 37°C and 
rinsed 3 times in PBS. Sections were incubated in a peroxidase substrate 
solution using DAB (Vector Laboratories) for stable purple staining and 
rinsed in pure water. Finally, sections were stained in hematoxylin for 5 
seconds, rinsed in pure water, dehydrated, cleared, and coverslipped. We 
examined the stained sections using an Olympus IX-81 microscope. The 
antibodies mentioned above were dissolved in PBS.
Parabiosis. WT (CD45.2+) and CD45.1+ B6 female mice controlled for 
age and weight were parabiosed for 14 days, following guidelines from the 
laboratory of Michel Nussenzweig (Rockefeller University, New York, New 
York, USA) (47). Prior to surgery, the mice were co-housed, shaved, and 
weighed. A longitudinal incision was made along the lateral aspect of each 
mouse. The mice were then joined at the elbow and knee with dissolvable 
sutures and the incision was closed with wound clips. Postoperative care 
included the administration of buprenex compound for pain manage-
ment, 5% dextrose and 0.9% sodium chloride, nutritional gel packs in each 
cage, and antibiotics (Sulfatrim) in the drinking water for the duration of 
the experiment. The procedure was approved by the Animal Studies Com-
mittee at Washington University.
Statistics. Statistical significance of differences was determined by Stu-
dent’s t tests for 2 groups or ANOVA for 3 groups. P values less than 0.05 
were considered significant.
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CHS. On days 0 and 1, the shaved abdominal skin of mice was painted 
with 50 μl 5% OXA (Sigma-Aldrich) in a solution of acetone/methanol (1:1) 
or 0.5% FITC (Sigma-Aldrich) in dibutylphthalate. These mice were used as 
donors for cell sorting and transfer on day 4. One month later, the right ear 
of recipients was challenged with 20 μl 1% OXA or 0.5% FITC, and their left 
ear was painted with vehicle. Ear thickness was measured every 24 hours 
with a micrometer. To account for acute hapten-induced irritation, back-
ground swelling was measured in the naive mice, which did not receive 
sensitized donor cells. Antigen-specific ear swelling was calculated as fol-
lows: (treated ear thickness – control ear thickness) – background swelling.
Migration of FITC carrier cells. Rag1–/– or WT B6 mice were sensitized on 
days 0 and 1 by painting their shaved abdominal skin with 100 μl 0.5% 
FITC. On day 2, sensitized mice were analyzed by flow cytometry for exami-
nation of FITC+ cells in different tissues.
Gene expression profile analysis of NK cell subsets. We sorted DX5–NK1.1+CD3– 
cells and DX5+NK1.1+CD3– cells from the liver of naive B6 WT mice. For 
each sample, we extracted total RNA using Trizol (Invitrogen), then puri-
fied RNA using the RNeasy Mini Kit (QIAGEN). We confirmed RNA qual-
ity and absence of genomic DNA contamination with a Bioanalyzer (Agi-
lent Technologies). RNA from each sample was processed with 2-round 
amplification according to standard Affymetrix protocols, and then 
hybridized to mouse 430 2.0 chips (Affymetrix). Fluorescence was detected 
with the Affymetrix GeneChip Scanner 3000 and image analysis was done 
using Affymetrix GeneChip Operating Software (GCOS). For functional 
classification of differentially expressed genes, we analyzed data using 
terms from the Gene Ontology (GO) project.
Surgical methods to collect blood from different vessels. Mice were 
intraperitoneally injected with pentobarbital sodium (75 mg/kg; Merck) 
for anesthetization. To obtain portal venous blood and postcaval venous 
blood, we collected about 150 μl of blood from portal vein or postcaval 
vein in the abdominal cavity using scalp vein needles and negative-pressure 
tubes. We transected the thoracic aorta to collect aortic blood. The post-
caval vein in the thoracic cavity, the portal vein, and the hepatic artery were 
ligatured with wire before the thoracic aorta was cut to exclude interfer-
ence of sinusoidal blood in the liver. After collecting thoracic aortic blood, 
we transected the postcaval vein in the abdominal cavity and collected the 
outflowing sinusoidal blood.
Immunofluorescence. Frozen sections of liver (10-μm) were fixed in 
a cold mixture of methanol/acetone (1:1) for 10 minutes. After fixa-
tion, an FcR-blocking step was performed with purified anti-CD16/32 
(BD Biosciences) at room temperature for 30 minutes. For confocal 
immunofluorescence of hepatic CD49a+ NK cells and endothelial cells, sec-
tions were stained with eFluor 660–anti-NKp46 (eBioscience), PE-labeled 
CD49a (BD Biosciences), and eFluor450–anti-CD31 (eBioscience) at room 
temperature for 60 minutes. For confocal immunofluorescence of hepatic 
DX5– NK cells and endothelial cells, sections were stained with PE–anti-
NKp46 (eBioscience), APC–anti-CD49b (BD Biosciences), and eFluor 450–
anti-CD31 (eBioscience). Stained sections were examined using a Carl Zeiss 
LSM 710 microscope. The antibodies mentioned above were dissolved in 
3% BSA/PBS and used in a dilution of 1:100.
Histology. Liver specimens from Rag1–/– mice were fixed in 4% 
paraformaldehyde, dehydrated with a graded series of alcohol, and 
embedded in paraffin. Seven-micrometer-thick paraffin sections were 
de-paraffinized and hydrated. For peroxidase blocking, sections were 
incubated in 3% hydrogen peroxidase in PBS for 10 minutes at room 
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